These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis. Deindl E; Ziegelhöffer T; Kanse SM; Fernandez B; Neubauer E; Carmeliet P; Preissner KT; Schaper W FASEB J; 2003 Jun; 17(9):1174-6. PubMed ID: 12692088 [TBL] [Abstract][Full Text] [Related]
5. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. Zhang G; Kim H; Cai X; López-Guisa JM; Alpers CE; Liu Y; Carmeliet P; Eddy AA J Am Soc Nephrol; 2003 May; 14(5):1254-71. PubMed ID: 12707394 [TBL] [Abstract][Full Text] [Related]
6. Role of plasminogen activators and urokinase receptor in platelet kinetics. Piguet PF; Vesin C; Da Laperousaz C; Rochat A Hematol J; 2000; 1(3):199-205. PubMed ID: 11920190 [TBL] [Abstract][Full Text] [Related]
7. Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA. Gyetko MR; Sud S; Sonstein J; Polak T; Sud A; Curtis JL J Immunol; 2001 Nov; 167(10):5539-42. PubMed ID: 11698423 [TBL] [Abstract][Full Text] [Related]
8. The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor. Avraham Y; Amer J; Doron S; Abu-Tair L; Mahamid M; Khatib A; Berry EM; Safadi R Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(12):G1364-72. PubMed ID: 22517772 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Busso N; Péclat V; So A; Sappino AP Ann Rheum Dis; 1997 Sep; 56(9):550-7. PubMed ID: 9370880 [TBL] [Abstract][Full Text] [Related]
10. Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness. Buø L; Meling GI; Karlsrud TS; Johansen HT; Aasen AO Hum Pathol; 1995 Oct; 26(10):1133-8. PubMed ID: 7557947 [TBL] [Abstract][Full Text] [Related]
11. Endogenous urokinase lacks antifibrotic activity during progressive renal injury. Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128 [TBL] [Abstract][Full Text] [Related]
12. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903 [TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225 [TBL] [Abstract][Full Text] [Related]
16. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Safadi R; Ohta M; Alvarez CE; Fiel MI; Bansal M; Mehal WZ; Friedman SL Gastroenterology; 2004 Sep; 127(3):870-82. PubMed ID: 15362042 [TBL] [Abstract][Full Text] [Related]
17. Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue. Dow MP; Bakke LJ; Cassar CA; Peters MW; Pursley JR; Smith GW Biol Reprod; 2002 May; 66(5):1413-21. PubMed ID: 11967205 [TBL] [Abstract][Full Text] [Related]
18. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target. McGuire PG; Jones TR; Talarico N; Warren E; Das A Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081 [TBL] [Abstract][Full Text] [Related]
19. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain. Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568 [TBL] [Abstract][Full Text] [Related]
20. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]